Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Early, G. L.
Right arrow Articles by Kilman, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Early, G. L.
Right arrow Articles by Kilman, J. W.

Chest, Vol 87, 467-469, Copyright © 1985 by American College of Chest Physicians

ARTICLES

Open lung biopsy. Its effects on therapy in the pediatric patient

GL Early, TE Williams and JW Kilman

The records of 35 pediatric patients who had open lung biopsies at Columbus Children's Hospital, Columbus, Ohio, were analyzed to determine the results and the effects on therapy. Twenty-two (63 percent) of these patients were immunocompromised, and they are compared to the non-compromised group. A diagnosis was obtained in all cases. An infectious agent was identified in 13 (37 percent) of the patients. Ten of these were immunocompromised. In 43 percent (15 patients) of the total group and 55 percent (12 patients) of the immunocompromised group, the results of the biopsy effected a change in therapy. Five patients died, all of whom were immunosuppressed. None died as a direct result of the open lung biopsy. The total morbidity rate was 23 percent (eight patients). We concluded that open lung biopsy can be accomplished safely in the pediatric patient and that the results affect the therapeutic decision-making process a significant portion of the time.


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
M. T. Jaklitsch, B. C. Linden, E. A. Braunlin, R. M. Bolman III, and J. E. Foker
Open-lung biopsy guides therapy in children
Ann. Thorac. Surg., June 1, 2001; 71(6): 1779 - 1785.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. K. Kim, C. Y. Chung, J. S. Kim, W. S. Kim, Y. Park, and Y. Y. Koh
Late Abnormal Findings on High-Resolution Computed Tomography After Mycoplasma Pneumonia
Pediatrics, February 1, 2000; 105(2): 372 - 378.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
M. R. Kramer, N. Berkman MBBCh, B. Mintz, S. Godfrey, M. Saute, and G. Amir MBBCH
The Role of Open Lung Biopsy in the Management and Outcome of Patients With Diffuse Lung Disease
Ann. Thorac. Surg., January 1, 1998; 65(1): 198 - 202.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. Davies, S. Dolgin, and M. Kattan
Morbidity and Mortality of Open Lung Biopsy in Children
Pediatrics, May 1, 1997; 99(5): 660 - 664.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American College of Chest Physicians.